Perturbation of hyaluronan metabolism predisposes patients with type 1 diabetes mellitus to atherosclerosis

Diabetologia

Volumn 50, Issue 6, 2007, Pages 1288-1293

  Nieuwdorp, M ^a   Holleman, F ^a   De Groot, E ^a   Vink, H ^a,b   Gort, J ^a   Kontush, A ^c   Chapman, M J ^c   Hutten, B A ^a   Brouwer, C B ^d   Hoekstra, J B L ^a   Kastelein, J J P ^a   Stroes, E S G ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b MAASTRICHT UNIVERSITY   (Netherlands)

^c PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^d Onze Lieve Vrouwe Gasthuis ^*  (Netherlands)

Author keywords

Hyaluronan; Hyaluronidase; Intima media thickness; Type 1 diabetes mellitus

Indexed keywords

C REACTIVE PROTEIN; HEMOGLOBIN A1C; HYALURONIC ACID; HYALURONIDASE;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ARTERY INTIMA; ARTERY MEDIA; ARTICLE; ATHEROSCLEROSIS; CAROTID ARTERY; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE COURSE; DISEASE PREDISPOSITION; ENZYME ACTIVITY; FEMALE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PRIORITY JOURNAL; SCHOOL CHILD; SEX RATIO; STATISTICAL SIGNIFICANCE; UNIVARIATE ANALYSIS;

ADOLESCENT; ADULT; AGED; ATHEROSCLEROSIS; CAROTID ARTERIES; CHILD; DIABETES MELLITUS, TYPE 1; DIABETIC ANGIOPATHIES; HUMANS; HYALURONIC ACID; HYALURONOGLUCOSAMINIDASE; MIDDLE AGED; TUNICA INTIMA; TUNICA MEDIA;

EID: 34247842825     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00125-007-0666-4     Document Type: Article

References (31)

1. Nathan DM, Cleary PA, Backlund JY et al, Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study Research group (2005) Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N Engl J Med 353:2643-2653
2. Soedamah-Muthu SS, Fuller JH, Mulnier HE, Raleigh VS, Lawrenson RA, Colhoun HM (2006) High risk of cardiovascular disease in patients with type 1 diabetes in the UK: a cohort study using the general practice research database. Diabetes Care 29:798-804
3. Nathan DM, Lachin J, Cleary P et al (2003) Intensive diabetes therapy and carotid intima-media thickness in type 1 diabetes mellitus. N Engl J Med 348:2294-2303
4. Hayaishi-Okano R, Yamasaki Y, Katakami N et al (2002) Elevated C-reactive protein associates with early-stage carotid atherosclerosis in young subjects with type 1 diabetes. Diabetes Care 25:1432-1438
5. Schaumberg DA, Glynn RJ, Jenkins AJ et al (2005) Effect of intensive glycemic control on levels of markers of inflammation in type 1 diabetes mellitus in the Diabetes Control and Complications Trial. Circulation 111:2446-2453
6. Nieuwdorp M, Meuwese MC, Vink H, Hoekstra JB, Kastelein JJ, Stroes ES (2005) The endothelial glycocalyx: a potential barrier between health and vascular disease. Curr Opin Lipidol 16:507-511
7. Nieuwdorp M, van Haeften TW, Gouverneur MCLG et al (2006) Loss of endothelial glycocalyx during acute hyperglycemia coincides with endothelial dysfunction and coagulation activation in vivo. Diabetes 55:480-486
8. Nieuwdorp M, Mooij HL, Kroon J et al (2006) Endothelial glycocalyx damage coincides with microalbuminuria in type 1 diabetes. Diabetes 55:1127-1132
9. Henry CB, Duling BR (1999) Permeation of the luminal capillary glycocalyx is determined by hyaluronan. Am J Physiol 277:H508-H514
10. van den Berg BM, Vink H, Spaan JA (2003) The endothelial glycocalyx protects against myocardial edema. Circ Res 92:592-594
11. Vink H, Constantinescu AA, Spaan JA (2000) Oxidized lipoproteins degrade the endothelial surface layer: implications for platelet-endothelial cell adhesion. Circulation 101:1500-1502
12. Chajara A, Raoudi M, Delpech B, Leroy M, Basuyau JP, Levesque H (2000) Circulating hyaluronan and hyaluronidase are increased in diabetic rats. Diabetologia 43:387-388
13. Ikegami-Kawai M, Okuda R, Nemoto T, Inada N, Takahashi T (2004) Enhanced activity of serum and urinary hyaluronidases in streptozotocin-induced diabetic Wistar and GK rats. Glycobiology 14:65-72
14. Chai S, Chai Q, Danielsen CC, Hjorth P et al (2005) Overexpression of hyaluronan in the tunica media promotes the development of atherosclerosis. Circ Res 96:583-591
15. Heickendorff L, Ledet T, Rasmussen LM (1994) Glycosaminoglycans in the human aorta in diabetes mellitus: a study of tunica media from areas with and without atherosclerotic plaque. Diabetologia 37:286-292
16. Lindqvist U (1997) Is serum hyaluronan a helpful tool in the management of patients with liver diseases? J Intern Med 242:67-71
17. Frost GI, Stern R (1997) A microtiter-based assay for hyaluronidase activity not requiring specialized reagents. Anal Biochem 251:263-269
18. de Groot E, Hovingh GK, Duriez P, Smit AJ, Fruchart JC, Kastelein JJP (2004) Measurement of arterial wall thickness as a surrogate marker for atherosclerosis. Circulation 109(23 Suppl 1):III33-III38
19. Wiegman A, Hutten BA, de Groot E et al (2004) Efficacy and safety of statin therapy in children with familial hypercholesterolemia: a randomized controlled trial. JAMA 292:331-337
20. Kornerup K, Nordestgaard BG, Feldt-Rasmussen B, Borch-Johnsen K, Jensen KS, Jensen JS (2003) Increased transvascular low density lipoprotein transport in insulin dependent diabetes: a mechanistic model for development of atherosclerosis. Atherosclerosis 170:163-168
21. Renard CB, Kramer F, Johansson F et al (2004) Diabetes and diabetes-associated lipid abnormalities have distinct effects on initiation and progression of atherosclerotic lesions. J Clin Invest 114:659-668
22. Wasty F, Alavi MZ, Moore S (1993) Distribution of glycosaminoglycans in the intima of human aortas: changes in atherosclerosis and diabetes mellitus. Diabetologia 36:316-322
23. Kolodgie FD, Burke AP, Farb A et al (2002) Differential accumulation of proteoglycans and hyaluronan in culprit lesions: insights into plaque erosion. Arterioscler Thromb Vasc Biol 22:1642-1648
24. van den Berg BM, Spaan JA, Rolf TM, Vink H (2006) Atherogenic region and diet diminish glycocalyx dimension and increase intima media ratios at the murine carotid artery bifurcation. Am J Physiol Heart Circ Physiol 290:H915-H920
25. Lehto S, Niskanen L, Suhonen M, Ronnemaa T, Laakso M (1996) Medial artery calcification. A neglected harbinger of cardiovascular complications in non-insulin-dependent diabetes mellitus. Arterioscler Thromb Vasc Biol 16:978-983
26. Fischer JW, Steitz SA, Johnson PY et al (2004) Decorin promotes aortic smooth muscle cell calcification and colocalizes to calcified regions in human atherosclerotic lesions. Arterioscler Thromb Vasc Biol 24:2391-2396
27. Mio K, Stern R (2002) Inhibitors of the hyaluronidases. Matrix Biol 21:31-37
28. Botzki A, Rigden DJ, Braun S et al (2004) L-Ascorbic acid 6-hexadecanoate, a potent hyaluronidase inhibitor. X-ray structure and molecular modeling of enzyme-inhibitor complexes. J Biol Chem 279:45990-45997
29. O'Leary DH, Polak JF, Kronmal RA, Manolio TA, Burke GL, Wolfson SK Jr (1999) Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. Cardiovascular Health Study Collaborative Research Group. N Engl J Med 340:14-22
30. Hodis HN, Mack WJ, LaBree L et al (1998) The role of carotid arterial intima-media thickness in predicting clinical coronary events. Ann Intern Med 128:262-269
31. Tarbell JM, Pahakis MY (2006) Mechanotransduction and the glycocalyx. J Intern Med 259:339-350